Multiple Myeloma Clinical Trials in Orange, California

4 studies are recruiting for multiple myeloma in Orange, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

   Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation antigen (BCMA) x clus…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Chao Family Comprehensive Cancer Center UCI, Orange, California

   Locations

   56 in total

   Run by

   Takeda

   See if you can join NCT06980480 on ClinicalTrials.gov

2. A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

   The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of California Irvine Medical Center, Orange, California

   Locations

   151 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07518186 on ClinicalTrials.gov

3. Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

   This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab Parent Studies.

   Stage

   Phase 4

   Ages

   18 and older

   Site

   UC Irvine Health, Orange, California

   Locations

   33 in total

   Run by

   Pfizer

   See if you can join NCT06057402 on ClinicalTrials.gov

4. A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

   This study is researching an experimental drug called linvoseltamab (called "study drug"). The study is focused on participants with newly diagnosed multiple myeloma (NDMM) who are eligible for high dose chemotherapy with autologous stem cell transplantation (transplant-eligible) or ineligible for …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UC Irvine Health, Orange, California

   Locations

   32 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT05828511 on ClinicalTrials.gov